Type
Metabolic / GLP-1
Duration
45 min
What's included
6 deliverables in this treatment
- Initial medical consultation and eligibility assessment
- Baseline metabolic blood panel
- GLP-1 medication (oral semaglutide or injectable liraglutide)
- Dose titration protocol and side effect management
- Follow-up monitoring and blood tests
- Dietary and lifestyle guidance
A medically supervised GLP-1 receptor agonist programme using semaglutide or liraglutide for men and women with excess weight or obesity. Includes metabolic baseline testing, personalised dosing with slow titration and ongoing monitoring and lifestyle support.
About this treatment
Dr Tan Medical Center's GLP-1 weight management programme offers supervised access to glucagon-like peptide-1 (GLP-1) receptor agonists — the most clinically effective pharmacological tool currently available for obesity and metabolic syndrome. Dr Tan Kok Kuan is a member of the Singapore Association for the Study of Obesity and has extensive experience in medical weight loss, combining evidence-based pharmacotherapy with personalised lifestyle guidance.
GLP-1 receptor agonists mimic the action of the naturally occurring intestinal hormone GLP-1, which is released after eating. They slow gastric emptying, reduce appetite, increase satiety signalling to the brain and — particularly in the case of semaglutide — also act centrally in the hypothalamus to reduce food-seeking behaviour. Clinical trials show that semaglutide (Ozempic/Wegovy) achieves an average of 15% body weight reduction over 68 weeks, with…
The programme begins with a full medical consultation to assess eligibility. The doctor takes a history of the patient's weight trajectory, dietary patterns, physical activity, sleep quality, previous weight loss attempts and any medications or conditions that may affect GLP-1 safety (contraindications include personal or family history of medullary thyroid carcinoma or MEN2 syndrome). A baseline metabolic blood panel is ordered: fasting glucose, fasting…
Good to know
- Led by member of Singapore Association for the Study of Obesity
- Oral (Rybelsus) and injectable (Saxenda) GLP-1 options
- Slow titration protocol to minimise side effects
- Metabolic monitoring built into programme
Treatment highlights
- Initial medical consultation and eligibility assessment
- Baseline metabolic blood panel
+4 more items in What's included
From SGD 600 per month for GLP-1 medication. Oral semaglutide (Rybelsus) and liraglutide (Saxenda) available. Initial consultation and baseline metabolic blood panel billed separately. Enquire for current programme pricing and medication availability.